News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Telix Pharmaceuticals.
RELATED STOCKHEAD STORIES
Health & Biotech
ASX Biotech Stocks: A big red kidney dialysis bus and Recce reduces SARS-CoV-2 in hamsters
Health & Biotech
Clinical Trials 101: How to spot a clinical trial with a strong chance of getting a drug to market
Health & Biotech
ASX Health Stocks: Patrys crosses brain barrier, opens up possibilities for its deoxymab antibody
News
ASX Large Caps: ASX 200 erases weekly loss, UK-exposed stocks rally on Truss U-turn
Health & Biotech
ASX Health Stocks: Canada says yes to Telix, while EBR keeps market in suspense over pending announcement
Experts
ScoPo’s Powerplays: Calmer week for ASX health stocks with some alarming stats about how many people drink instant coffee
News
ASX Large Caps: ASX on the offensive in Q4, up another 1.7pc; RBNZ hikes 50bp
News
ASX Large Caps: Lithium stocks dumped, Telix plunges 16pc, while RBA tells ASX to shape up
Health & Biotech
ASX Health Stocks: Telix and Imugene keep making progress on cancer studies
Experts
ScoPo’s Powerplays: Reporting season positive as ASX health stocks head in right direction
News
ASX Large Caps: Blue chips down 0.3pc as Tech continues volatile ride
Health & Biotech
ASX Health Stocks: Respiri lifts 14pc after giving update on US market
Health & Biotech
ASX Health Stocks: Mesoblast raise signals potential comeback for biotechs
Experts
ScoPo’s Powerplays: ‘Big haircuts’ for ASX health stocks – Morgans reviews quarterly results
Stockhead TV
V-Con: Small Cap Showcase Part 2 – Finding strong companies in a weak market
Experts
ScoPo’s Powerplays: ASX health stocks catch a strong bid in July rally
News